Page 811 - Williams Hematology ( PDFDrive )

786 Part VI: The Erythrocyte Chapter 49: Disorders of Hemoglobin Structure: Sickle Cell Anemia and Related Abnormalities 787

244. Akinyoola AL, Adediran IA, Asaleye CM, et al: Risk factors for osteonecrosis of the 278. Condon PI, Serjeant GR: Behaviour of untreated proliferative sickle retinopathy. Br J
femoral head in patients with sickle cell disease. Int Orthop 33(4):923–926, 2009. Ophthalmol 64(6):404–411, 1980.
245. Baldwin C, Nolan VG, Wyszynski DF, et al: Association of Klotho, bone morpho- 279. Liem RI, Calamaras DM, Chhabra MS, et al: Sudden-onset blindness in sickle cell dis-
genic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood ease due to retinal artery occlusion. Pediatr Blood Cancer 50(3):624–627, 2008.
106(1):372–375, 2005. 280. Paton D: The conjunctival sign of sickle-cell disease. Arch Ophthalmol 66:90–94, 1961.
246. Milner P, Kraus AP, Sebes JJ, et al: Osteonecrosis of the humeral head in sickle cell 281. Paton D: The conjunctival sign ox sickle-cell disease. Further observations. Arch Oph-
disease. Clin Orthop Relat Res 289:136–143, 1993. thalmol 68:627–632, 1962.
247. Hernigou P, Bachir D, Galacteros F: The natural history of symptomatic osteonecrosis 282. Cheung AT, Chen PC, Larkin EC, et al: Microvascular abnormalities in sickle cell dis-
in adults with sickle-cell disease. J Bone Joint Surg Am 85-A(3):500–504, 2003. ease: A computer-assisted intravital microscopy study. Blood 99(11):3999–4005, 2002.
248. Hernigou P, Habibi A, Bachir D, et al: The natural history of asymptomatic osteone- 283. Knisely MH, Bloch EH, Eliot TS, et al: Sludged blood. Science 106(2758):431–440, 1947.
crosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 284. Curran EL, Fleming JC, Rice K, et al: Orbital compression syndrome in sickle cell dis-
88(12):2565–2572, 2006. ease. Ophthalmology 104(10):1610–1615, 1997.
249. Neumayr LD, Aguilar C, Earles AN, et al: Physical therapy alone compared with core 285. Sayag D, Binaghi M, Souied EH, et al: Retinal photocoagulation for proliferative sickle
decompression and physical therapy for femoral head osteonecrosis in sickle cell dis- cell retinopathy: A prospective clinical trial with new sea fan classification. Eur J Oph-
ease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint thalmol 18(2):248–254, 2008.
Surg Am 88(12):2573–2582, 2006. 286. Fox PD, Minninger K, Forshaw ML, et al: Laser photocoagulation for proliferative
250. Hernigou P, Zilber S, Filippini P, et al: Total THA in adult osteonecrosis related to sickle retinopathy in sickle haemoglobin C disease. Eye (Lond) 7(Pt 5):703–706, 1993.
cell disease. Clin Orthop Relat Res 466(2):300–308, 2008. 287. Fox PD, Vessey SJ, Forshaw ML, et al: Influence of genotype on the natural history
251. Moran MC, Huo MH, Garvin KL, et al: Total hip arthroplasty in sickle cell hemoglo- of untreated proliferative sickle retinopathy—An angiographic study. Br J Ophthalmol
binopathy. Clin Orthop Relat Res (294):140–148, 1993. 75(4):229–231, 1991.
252. Acurio MT, Friedman RJ: Hip arthroplasty in patients with sickle-cell haemoglobinop- 288. Rogers ZR, Wang WC, Luo Z, et al: Biomarkers of splenic function in infants with sickle
athy. J Bone Joint Surg Br 74(3):367–371, 1992. cell anemia: Baseline data from the BABY HUG Trial. Blood 117(9):2614–2617, 2011.
253. Nolan VG, Adewoye A, Baldwin C, et al: Sickle cell leg ulcers: Associations with haemo- 289. Brousse V, Buffet P, Rees D: The spleen and sickle cell disease: The sick(led) spleen. Br J
lysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol Haematol 166(2):165–176, 2014.
133(5):570–578, 2006. 290. Pearson HA, Spencer RP, Cornelius EA: Functional asplenia in sickle-cell anemia. N
254. Koshy M, Entsuah R, Koranda A, et al: Leg ulcers in patients with sickle cell disease. Engl J Med 281(17):923–926, 1969.
Blood 74(4):1403–1408, 1989. 291. Ferster A, Bujan W, Corazza F, et al: Bone marrow transplantation corrects the splenic
255. Best PJ, Daoud MS, Pittelkow MR, et al: Hydroxyurea-induced leg ulceration in 14 reticuloendothelial dysfunction in sickle cell anemia. Blood 81(4):1102–1105, 1993.
patients. Ann Intern Med 128(1):29–32, 1998. 292. Buchanan GR, McKie V, Jackson EA, et al: Splenic phagocytic function in children with
256. Halabi-Tawil M, Lionnet F, Girot R, et al: Sickle cell leg ulcers: A frequently disabling sickle cell anemia receiving long-term hypertransfusion therapy. J Pediatr 115(4):568–
complication and a marker of severity. Br J Dermatol 158(2):339–344, 2008. 572, 1989.
257. Wethers DL, Ramirez GM, Koshy M, et al: Accelerated healing of chronic sickle-cell leg 293. Claster S, Vichinsky E: First report of reversal of organ dysfunction in sickle cell anemia
ulcers treated with RGD peptide matrix. RGD Study Group. Blood 84(6):1775–1779, by the use of hydroxyurea: Splenic regeneration. Blood 88(6):1951–1953, 1996.
1994. 294. Naik RP, Lanzkron S: Baby on board: What you need to know about pregnancy in the
258. Sher GD, Olivieri NF: Rapid healing of chronic leg ulcers during arginine butyrate ther- hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2012:208–214, 2012.
apy in patients with sickle cell disease and thalassemia. Blood 84(7):2378–2380, 1994. 295. Sun PM, Wilburn W, Raynor BD, et al: Sickle cell disease in pregnancy: Twenty years
259. Traina F, Jorge SG, Yamanaka A, et al: Chronic liver abnormalities in sickle cell disease: of experience at Grady Memorial Hospital, Atlanta, Georgia. Am J Obstet Gynecol
A clinicopathological study in 70 living patients. Acta Haematol 118(3):129–135, 2007. 184(6):1127–1130, 2001.
260. Banerjee S, Owen C, Chopra S: Sickle cell hepatopathy. Hepatology 33(5):1021–1028, 296. Boulet SL, Okoroh EM, Azonobi I, et al: Sickle cell disease in pregnancy: Maternal com-
2001. plications in a Medicaid-enrolled population. Matern Child Health J 17(2):200–207,
261. West MS, Wethers D, Smith J, et al: Laboratory profile of sickle cell disease: A cross- 2013.
sectional analysis. The Cooperative Study of Sickle Cell Disease. J Clin Epidemiol 297. Villers MS, Jamison MG, De Castro LM, et al: Morbidity associated with sickle cell
45(8):893–909, 1992. disease in pregnancy. Am J Obstet Gynecol 199(2):125 e1–e5, 2008.
262. Koskinas J, Manesis EK, Zacharakis GH, et al: Liver involvement in acute vaso-oc- 298. James AH, Jamison MG, Brancazio LR, et al: Venous thromboembolism during preg-
clusive crisis of sickle cell disease: Prevalence and predisposing factors. Scand J Gas- nancy and the postpartum period: Incidence, risk factors, and mortality. Am J Obstet
troenterol 42(4):499–507, 2007. Gynecol 194(5):1311–1315, 2006.
263. Buchanan GR, Glader BE: Benign course of extreme hyperbilirubinemia in sickle cell 299. Wilson JG, Scott WJ, Ritter EJ, et al: Comparative distribution and embryotoxicity of
anemia: Analysis of six cases. J Pediatr 91(1):21–24, 1977. hydroxyurea in pregnant rats and rhesus monkeys. Teratology 11(2):169–178, 1975.
264. Johnson CS, Omata M, Tong MJ, et al: Liver involvement in sickle cell disease. Medicine 300. Thauvin-Robinet C, Maingueneau C, Robert E, et al: Exposure to hydroxyurea during
(Baltimore) 64(5):349–356, 1985. pregnancy: A case series. Leukemia 15(8):1309–1311, 2001.
265. Shao SH, Orringer EP: Sickle cell intrahepatic cholestasis: Approach to a difficult prob- 301. Austin H, Lally C, Benson JM, et al: Hormonal contraception, sickle cell trait, and risk
lem. Am J Gastroenterol 90(11):2048–2050, 1995. for venous thromboembolism among African American women. Am J Obstet Gynecol
266. Ahn H, Li CS, Wang W: Sickle cell hepatopathy: Clinical presentation, treatment, and 200(6):620 e1–3, 2009.
outcome in pediatric and adult patients. Pediatr Blood Cancer 45(2):184–190, 2005. 302. Zarrouk V, Habibi A, Zahar JR, et al: Bloodstream infection in adults with sickle cell
267. Sheehy TW: Sickle cell hepatopathy. South Med J 70(5):533–538, 1977. disease: Association with venous catheters, Staphylococcus aureus, and bone-joint
268. Schubert TT: Hepatobiliary system in sickle cell disease. Gastroenterology 90(6):2013– infections. Medicine (Baltimore) 85(1):43–48, 2006.
2021, 1986. 303. Mollapour E, Porter JB, Kaczmarski R, et al: Raised neutrophil phospholipase A2 activ-
269. Suell MN, Horton TM, Dishop MK, et al: Outcomes for children with gallbladder ity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell dis-
abnormalities and sickle cell disease. J Pediatr 145(5):617–621, 2004. ease. Blood 91(9):3423–3429, 1998.
270. Rennels MB, Dunne MG, Grossman NJ, et al: Cholelithiasis in patients with major 304. Overturf GD: Infections and immunizations of children with sickle cell disease. Adv
sickle hemoglobinopathies. Am J Dis Child 138(1):66–67, 1984. Pediatr Infect Dis 14:191–218, 1999.
271. Bond LR, Hatty SR, Horn ME, et al: Gall stones in sickle cell disease in the United 305. Sullivan JL, Ochs HD, Schiffman G, et al: Immune response after splenectomy. Lancet
Kingdom. Br Med J (Clin Res Ed) 295(6592):234–236, 1987. 1(8057):178–181, 1978.
272. Vasavda N, Menzel S, Kondaveeti S, et al: The linear effects of alpha-thalassaemia, the 306. Barrett-Connor E: Bacterial infection and sickle cell anemia. An analysis of 250 infec-
UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Hae- tions in 166 patients and a review of the literature. Medicine (Baltimore) 50(2):97–112,
matol 138(2):263–270, 2007. 1971.
273. To KW, Nadel AJ: Ophthalmologic complications in hemoglobinopathies. Hematol 307. Zarkowsky HS, Gallagher D, Gill FM, et al: Bacteremia in sickle hemoglobinopathies. J
Oncol Clin North Am 5(3):535–548, 1991. Pediatr 109(4):579–585, 1986.
274. Mohan JS, Lip PL, Blann AD, et al: The angiopoietin/Tie-2 system in proliferative 308. Leikin SL, Gallagher D, Kinney TR, et al: Mortality in children and adolescents with
sickle retinopathy: Relation to vascular endothelial growth factor, its soluble receptor sickle cell disease. Cooperative Study of Sickle Cell Disease. Pediatrics 84(3):500–508,
Flt-1 and von Willebrand factor, and to the effects of laser treatment. Br J Ophthalmol 1989.
89(7):815–819, 2005. 309. Adamkiewicz TV, Sarnaik S, Buchanan GR, et al: Invasive pneumococcal infections
275. Aiello LP, Avery RL, Arrigg PG, et al: Vascular endothelial growth factor in ocular in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resis-
fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med tance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr 143(4):438–
331(22):1480–1487, 1994. 444, 2003.
276. Aiello LP, Northrup JM, Keyt BA, et al: Hypoxic regulation of vascular endothelial 310. Gaston MH, Verter JI, Woods G, et al: Prophylaxis with oral penicillin in children with
growth factor in retinal cells. Arch Ophthalmol 113(12):1538–1544, 1995. sickle cell anemia. A randomized trial. N Engl J Med 314(25):1593–1599, 1986.
277. Downes SM, Hambleton IR, Chuang EL, et al: Incidence and natural history of pro- 311. Halasa NB, Shankar SM, Talbot TR, et al: Incidence of invasive pneumococcal disease
liferative sickle cell retinopathy: Observations from a cohort study. Ophthalmology among individuals with sickle cell disease before and after the introduction of the pneu-
112(11):1869–1875, 2005. mococcal conjugate vaccine. Clin Infect Dis 44(11):1428–1433, 2007.

Kaushansky_chapter 49_p0759-0788.indd 786 9/18/15 3:02 PM